These vials are intended exclusively for research purposes, and researchers are urged to explore and contribute to the understanding of IGF-1 LR3s impact on cellular biology, metabolism, and muscle-related conditions
See our complete guide on how long peptides take to work for detailed timelines
References Madigan, M
Wegovy is an FDA-approved weight loss medication manufactured by Novo Nordisk, used for chronic weight management in adults and children 12 years and older who are obese (with a body mass index of 30 or higher) or overweight (with a body mass index of 27 or higher) with at least one weight-related medical condition such as cardiovascular disease, high blood pressure, high cholesterol or type 2 diabetes
A phase 2, multicenter, randomized, double-blind, placebo-controlled trial in the United States assessed the efficacy and safety of retatrutide in 338 adults aged 1875 years without diabetes but with obesity or overweight plus 1 weight-related condition for 48 weeks
In use, it was